Logo Image
News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers
Event Calendar

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Event Calendar
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement

Michael Murphy, MD, PhD

Advertisement

Chief Medical and Scientific Officer, Worldwide Clinical Trials

Articles by Michael Murphy, MD, PhD

Your Phase III Clinical Protocol Is Your Initial Product Launch

ByHarris Kaplan,Michael Murphy, MD, PhD
January 30th 2026

How demand-driven development will help new products be more successful.

Advertisement

Latest Updated Articles

  • Your Phase III Clinical Protocol Is Your Initial Product Launch
    Your Phase III Clinical Protocol Is Your Initial Product Launch

    January 30th 2026



Advertisement
Advertisement

Trending on PharmExec

1

FDA Grants Accelerated Approval to Zenbexus Plus Daratumumab and Hyaluronidase-fihj and Dexamethasone for Multiple Myeloma

2

The Road Ahead: Advice for Pharma's Next Board Meeting

3

AI at the FDA: Efficiency, Oversight, and Open Questions

4

From Value Imperative to Operating Reality: Rethinking Trust in Pharma

5

Pharma’s New Growth Equation: Smarter Deals, Stronger Science, Rising Costs

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us